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Resting state functional
connectivity predictors
of treatment response to
electroconvulsive therapy in
depression
M. Moreno-Ortega1,2, J. Prudic1, S. Rowny1, G. H. Patel1, A. Kangarlu4, S. Lee3, J. Grinband1,
T. Palomo 2,5, T. Perera1, M. F. Glasser6 & D. C. Javitt1
There is increasing focus on use of resting-state functional connectivity (RSFC) analyses to subtype
depression and to predict treatment response. To date, identification of RSFC patterns associated
with response to electroconvulsive therapy (ECT) remain limited, and focused on interactions between
dorsal prefrontal and regions of the limbic or default-mode networks. Deficits in visual processing are
reported in depression, however, RSFC with or within the visual network have not been explored in
recent models of depression. Here, we support prior studies showing in a sample of 18 patients with
depression that connectivity between dorsal prefrontal and regions of the limbic and default-mode
networks serves as a significant predictor. In addition, however, we demonstrate that including visual
connectivity measures greatly increases predictive power of the RSFC algorithm (>80% accuracy
of remission). These exploratory results encourage further investigation into visual dysfunction in
depression, and use of RSFC algorithms incorporating the visual network in prediction of response to
both ECT and transcranial magnetic stimulation (TMS), offering a new framework for the development
of RSFC-guided TMS interventions in depression.
Major depressive disorder (MDD) is a severe mental disorder that affects up to 20% of the population worldwide.
Approximately 50% of individuals with MDD fail to respond adequately to anti-depressant medications. For
individuals with treatment resistant depression (TRD) electroconvulsive therapy (ECT) is the most effective treatment. However, ECT requires general anesthesia and may be accompanied by adverse cognitive effects, reducing
its tolerability.
The response and remission rates for patients with depression without psychotic symptoms are 70% and 50%,
respectively1. As a result, a significant number of individuals may be exposed to the significant risks of ECT
without tangible benefit. At present, there are no measures available that are capable of differentiating responders
from non-responders, and thus from preventing unneeded treatments. Also, despite considerable research, neural mechanisms underlying ECT effectiveness remain largely unknown, inhibiting the search for safer or more
effective alternatives.
Prominent theories of both TRD and ECT response emphasize disruptions of resting state functional connectivity (RSFC) between large-scale brain networks in TRD that may be reversed with ECT treatment. To date,
such studies have focused most prominently on interactions between regions of the fronto-parietal network especially dorsolateral prefrontal cortex (DLPFC; BA46, BA9 and BA8) and limbic regions such as subgenual anterior
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cingulate cortex (sgACC; BA25) or amygdala, and on fronto-limbic dysconnectivity. Other RSFC networks2, such
as default-mode (DMN) and visual (VIS), have been investigated to a more limited extent.
The role of sgACC in TRD was first proposed ~20 years ago3–5 based on volumetric analysis, cerebral blood
flow (CBF) and glucose metabolism. These findings complemented prior results with DLPFC6–8. Subsequent studies suggested an additional role for fronto-limbic dysregulation in both depressive illness and healthy sadness9–11.
These theories led to development of experimental treatments such as deep brain stimulation (DBS) of the sgACC
for treatment of persistent depressive symptoms11–14. In addition, non-invasive brain stimulation approaches such
as transcranial magnetic stimulation (TMS) may be effective only to the degree that they effectively target regions
of DLPFC that are anti-correlated with sgACC15.
Successive studies have investigated sgACC connectivity and fronto-limbic balance in relationship to treatment response to antidepressant treatments, including ECT16–20. For example, in one recent study, increased fractional amplitude of low frequency fluctuation (fALFF) involving sgACC significantly predicted ECT response and
declined over time during ECT treatment. Functional connectivity between sgACC and additional limbic regions
were also significantly reduced over the course of treatment. Nevertheless, the degree of variance explained by
sgACC fALFF (~25%) was relatively modest and correlations between reduced fALFF and symptoms were not
significant21. Changes in RSFC within dorsal ACC, medial prefrontal (MPFC) and lateral parietal cortex22, and
between sgACC and DLPFC23 have also been associated with treatment improvement following ECT, but baseline
patterns have not been shown to predict response.
Disturbances in other networks, such as the DMN and VIS, have also been reported in depression and ECT
response, but have been less studied24. DMN is activated by internally focused cognitive processes such as mind
wandering, self-reference, remembering the past and planning the future25–27. Lack of DMN suppression has
been reported in depression during performance of cognitive demanding tasks28–31, and at rest32–35. DMN contains discrete anterior and posterior nodes in rostral MPFC and posterior cingulate (PCC) cortex, respectively36.
Dissociation within the DMN33,37 and anterior-to-posterior hyperconnectivity38 have also been associated with
depression.
The VIS cortex plays an important role in facial perception and expression as well as in emotion processing39,40.
Processing of facial expressions has a predictive power to discriminate MDD patients from healthy controls41–43,
and identifying patients who will respond to antidepressants44. Increased BOLD responses to sad stimuli in right
sgACC and VIS cortex may be predictive of clinical recovery45, and respond to antidepressant treatment46–48.
Deficits in VIS activation49,50 and processing of neutral facial51 expressions have also been reported in depression.
VIS perception, including functions such as contrast sensitivity, are altered in patients with depression, and
normalized with remission after antidepressive therapy52–54. Alterations in VIS association (higher order) regions
during perception, attention, working memory and VIS categorization may also occur in MDD55–57. Deficits are
observed even in tasks involving simple VIS stimuli with no demand on emotion processing49,50, suggesting a
basic dysfunction on processing information.
In this exploratory study, we evaluate RSFC pattern prior to and following ECT treatment, and evaluate both
predictors and clinical correlates of response. RSFC patterns between DLPFC and both DMN and VIS networks,
and between DMN and VIS as well as RSFC within these networks (“network homogeneity”) were computed.
Based upon the accumulating data regarding VIS dysfunction in MDD, we hypothesized that including VIS
connectivity along with that of more extensively studied fronto-limbic and DMN networks would significantly
enhance predictive value of network models.

Results

Mean symptom reduction following ECT was 62% (62.2 ± 5.9). Further, 9 patients out of 18 (50%) were classified as remitters and 9 patients out of 18 (50%) as non-remitters. After treatment, average HDRS-24 in remitter
(4.7 ± 0.8) differed from that of non-remitter (15.2 ± 1.3; p < 0.000). No significant differences in sex (60% female
vs. 60% female), age (53.2 ± 3.7 vs. 50.2 ± 4.5) or HDRS-24 baseline scores (25.8 ± 1.2 vs. 27.2 ± 1.4) were found
between remitters and non-remitters.

Response prediction.

Table 1 summarizes findings regarding pretreatment RSFC patterns within and
between DLPFC, DMN and VIS networks correlated to treatment response, with p-values greater than 0.05.
Reduced connectivity (less anticorrelated) between DLPFC and DMN, or between DMN and VIS, and reduced
connectivity (less correlated) between DLPFC and VIS, or within DLPFC, DMN or VIS, were associated with
improvement in depression scores. After multiple comparison correction, decreased connectivity within
aDMN(10r), between DLPFC(46) and aDMN(s32), or between DLPFC(p9-46v) and VIS(MT+), remained significant. Even if decreased connectivity within VIS(ventral) did not survive multiple comparison correction, it
added predictive value to final models. The main model involved pretreatment RSFC within aDMN(10r) and
VIS(ventral), with 100% accuracy of remission within this sample. Leave-one-out cross validation (LOOCV)
on FDR corrected models, adjusted by motion displacement regressors, showed 0.83–0.89 prediction accuracy.

DLPFC-sgACC/rostral ACC. Consistent with previous work15, connectivity (reduced anticorrelation)
between DLPFC(46, p9-46v) and sgACC(25) or rostral ACC(a24) were associated with treatment response but
did not survive to multiple comparison correction (Supplementary Results).
DLPFC-DMN.

A significant (r = 0.69, p = 0.002; Fig. 1A) correlation was observed between
DLPFC(46)-aDMN(s32) connectivity and treatment response, but not for DLPFC(p9-46v). Remitters showed
reduced anticorrelation compared to non-remitters (Fig. 1B). A ROC curve of this model showed significant
area under the curve (AUC = 0.89, p < 0.001, 95% CI: 0.67–1; Fig. 1C). No significant correlations were observed
between DLPFC(46, p9-46v) and pDMN(31pv, v23ab).
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Partial correlation analyses
Correlation analyses
Connectivity at baseline
Initial
DLPFCneg
analyses

r

r

Adjusted by AbsRMS

uncorrected
p-value

corrected
p-value

r

uncorrected
p-value

corrected
p-value

0.535

0.022

0.074

0.521

0.032

0.086

0.555

0.021

0.083

DLPFC(46)-aDMN(a24)

0.576

0.012

0.074

0.564

0.018

0.086

0.576

0.015

0.083

DLPFC(p9-46v)-aDMN(a24)

0.517

0.028

0.074

0.529

0.029

0.086

0.523

0.031

0.083

DLPFC(46)-aDMN(s32)

0.685

0.002

0.033

0.679

0.003

0.040

0.684

0.002

0.047

−0.610

0.007

0.091

−0.672

0.003

0.040

−0.663

0.004

0.047

0.490

0.039

0.164

0.475

0.054

0.171

0.496

0.043

0.181

Intra-DLPFC(46)

−0.500

0.035

0.164

−0.497

0.043

0.171

−0.500

0.041

0.181

Intra-DLPFC(p9-46v/46)

−0.490

0.039

0.164

−0.477

0.053

0.171

−0.524

0.031

0.181

Intra-aDMN(10r)

−0.699

0.001

0.033

−0.694

0.002

0.040

−0.709

0.001

0.047

Intra-aDMN(s32/10r)

−0.550

0.018

0.164

−0.537

0.026

0.171

−0.550

0.022

0.181

Intra-VIS(ventral)

−0.523

0.026

0.164

−0.531

0.028

0.171

−0.521

0.032

0.181

DLPFC(p9-46v)-MT+ (LO1)

−0.606

0.008

0.060

−0.593

0.012

0.065

−0.609

0.010

0.071

DLPFC(p9-46v)- MT+ (FST)

−0.661

0.003

0.045

−0.745

0.001

0.010

−0.740

0.001

0.011

DLPFC(p9-46v)-MT+ (V3CD)

−0.539

0.021

0.060

−0.523

0.031

0.067

−0.541

0.025

0.072

Intra-ventral(FFC/ventral)

−0.523

0.026

0.060

−0.525

0.030

0.067

−0.522

0.032

0.072

Intra-ventral(V8/ventral)

−0.532

0.023

0.060

−0.548

0.023

0.067

−0.531

0.028

0.072

Intra-ventral(PIT/ventral)

−0.564

0.015

0.060

−0.593

0.012

0.065

−0.566

0.018

0.071

Intra-ventral(VMV1/ventral)

−0.530

0.024

0.060

−0.516

0.034

0.067

−0.581

0.015

0.071

Intra-ventral(VMV3/ventral)

−0.487

0.040

0.081

−0.498

0.042

0.067

−0.486

0.048

0.096

aDMN(10r)-VIS(MT+)

Follow-up VIS
analyses

corrected
p-value

DLPFC(46)-sgACC(25)

DLPFC(p9-46v)-VIS(MT+)
Subsequent
network
analyses

Adjusted by RelRMS

uncorrected
p-value

Table 1. Connectivity measures at baseline and change in depression scores. The nomenclature used in this
table and along the results section is based on the HCP’s multimodal parcellation, each parcel used for analyses
appears in parenthesis preceded by the region to which it pertains; e.g., aDMN(10r) refers to parcels 10r
within the anterior medial locus of DMN (or aDMN), DLPFC(46) refers to parcel 46 within the DLPF, etc. For
visual system (or VIS) analyses, 2 levels of analyses were explored (VIS region vs. parcel within region); e.g.,
VIS(MT+) refers to the MT+ region within the visual system. In follow up VIS analyses, e.g., MT+ (FST)
refers to the parcel FST within the MT+ region, etc. Initial DLPFCneg analyses tested 8 correlations involving
RSFC between DLPFCneg(46, p9-46v, a9-46v, 9-46d) and sgACC(25) or rostral ACC(a24) to choose significant
(uncorrected p values) DLPFCneg parcels for subsequent network analyses. Subsequent network analyses tested
38 correlations involving RSFC within and between DLPFCneg(46, p9-46v), DMN or VIS networks. Follow-up
VIS analyses queried which parcels within MT+ (p = 9) and ventral (p = 7) were driving the observed regional
comparisons. These analyses used all parcels within each region and were therefore FDR corrected for 16
comparisons each. We include in Table 1 all significant (uncorrected p values) connections from correlation
analyses; those that survived multiple comparison correction controlling for FDR are highlighted.

DLPFC/DMN-VIS.

For DLPFC-VIS connectivity, a significant negative correlation was observed for baseline DLPFC(p9-46v)-VIS(MT+) (r = −0.61, p = 0.007; Fig. 2A) and treatment response, but not for DLPFC(46).
Remitters showed significantly greater anti-correlation between DLPFC(p9-46v)-VIS(MT+) at baseline than
non-remitters (Fig. 2B). In remitters, significant correlations with improvement were observed across multiple
parcels. AUC for this model was highly predictive of remission (AUC = 0.89, p < 0.001, 95% CI: 0.70–1; Fig. 2C).
By contrast, for DMN-VIS connectivity, a significant positive correlation with treatment response was found
for aDMN(10r)-VIS(MT+), but did not survive to multiple comparison correction (Supplementary Results).

Within-network connectivity. In addition to pairwise connectivity between networks, we also evaluated
connectivity within networks. Reduced connectivity within aDMN(10r) (r = −0.70, p = 0.001; Fig. 3A) correlated
with clinical improvement. Remitters showed significantly reduced intrinsic connectivity than non-remitters
(Fig. 3B). AUC for intra-aDMN(10r) (AUC = 0.89, p < 0.001, 95% CI: 0.67–1; Fig. 3C) significantly predicted
remission.
For VIS, reduced intrinsic connectivity within the ventral stream (intra-regional connectivity) predicted treatment response (r = −0.52, p = 0.03; Fig. 4A). Remitters showed less intrinsic connectivity than non-remitters
(Fig. 4B). The AUC for prediction of remission by intra-regional connectivity within the ventral stream was also
significant (AUC = 0.88, p = 0.001, 95% CI: 0.68–1; Fig. 4C).
Correlation between connectivity measures at baseline. We generated a correlation matrix of pair-

wise correlation between all pretreatment connections (Fig. 5A) within and between DLPFC, DMN and VIS
networks. These analyses most importantly revealed positive correlations between intra-aDMN and DLPFC-VIS
connectivity, or negative correlations between intra-aDMN and DLPFC-aDMN connectivity. Conversely,
intra-VIS connectivity was not correlated to intra-aDMN, DLPFC-VIS or DLPFC-aDMN connectivity.
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Figure 1. DLPFC, sgACC and rostral ACC inter-connectivity at baseline. (A) Correlation plot with baseline
RSFC data for DLPFC(46) – aDMN(s32) associated with improvement in depression (% change in depression
scores) ([pre-post/pre] × 100); brain images displayed at Cohen’s d values > 0 (Cohen’s d = 2t/sqrt(dfe)),
colors represent surface vertices with positive correlation (red-yellow) between RSFC data and improvement
in depression (% change in depression scores, [pre-post/pre] × 100). (B) Bar plot with baseline DLPFC(46) –
aDMN(s32) comparison between non-remitters and remitters; bars represent connectivity values; **p < 0.01.
Error bars represent standard error. (C) ROC curve analysis of DLPFC(46) – aDMN(s32) model. AUC, area
under the curve; p-val, from Likelihood Ratio Test.

Two Factor Models for prediction of magnitude of improvement.

No significant additivity was
observed for models involving only DLPFC and DMN regions. Specifically, the combination of sgACC(25) and
aDMN(24) did not show significantly increased predictive ability vs. DLPFC(46) connectivity to either region
alone (Supplementary Table 1).
By contrast, when either intrinsic ventral VIS connectivity or pairwise connectivity between VIS regions and
DLPFC or DMN were included, significant additive predictive values were obtained. Thus, the combination of
intrinsic ventral VIS connectivity with either intrinsic aDMN(10r) connectivity (Table 2, Model 1), pairwise connectivity between DLPFC(46)-aDMN(s32) (Table 2, Model 2) or DLPFC(p9-46v)-VIS(MT+) (Table 2, Model 3),
all resulted in significant improvements vs. the corresponding one-predictor models (R2 change ≥ 0.3, p < 0.05).
Each of these models accounted for ~60% of the variance in treatment response.

Two factor models for prediction of remission. Logistic regression analyses and LOOCV were used in
order to assess the degree to which the models shown above predicted remission. Intrinsic ventral VIS connectivity alone predicted 77.8% of remitters and non-remitters. The addition of intrinsic aDMN(10r) connectivity in
Model 1 (Table 3), increased predictive value to 100% accuracy for both remitters and non-remitters. In Model 2
(Table 3), the addition of DLPFC(46)-DMN(s32) connectivity, also improved predictive value, with 94% accuracy
of remission.
DLPFC(p9-46v)-VIS(MT+) connectivity alone predicted 83.3% (88.9% of remitters and 77.8% of
non-remitters). The addition of ventral VIS connectivity in Model 3 (Table 3), also increased predictive value
to 94% accuracy of remission. In ROC analyses, Models 1–3 (Fig. 5B) accounted for AUC values of 100%. In
LOOCV analyses, Models 1–3 showed 0.83–0.89 accuracy (Table 4).
Parcelwise analysis. Given the overall significant involvement of reduced connectivity with the MT+ com-

plex and within the ventral VIS region in prediction of ECT response, follow-up analyses explored connectivity
related to individual parcels of these regions.
At baseline, within the MT+ VIS region, strongest (negative) correlations were observed between the Fundal
area of the Superior Temporal (FST) sulcus (r = −0.66, p = 0.003) or the Lateral Occipital area 1 (LO1) (r = −0.61,
p = 0.008) and the DLPFC(p9-46v) (Table 1). DLPFC(p9-46v)-FST connectivity was highly predictive of remission (AUC = 0.91, p < 0.001, 95% CI: 0.75–1). By contrast, DLPFC(p9-46v)-LO1 connectivity had only a modest
predictive value (AUC = 0.77, p < 0.03; 95% CI: 0.51–0.99).
Within the ventral VIS region, strongest (negative) correlations were observed between the Fusiform Face
complex (FFC) (r = −0.52, p = 0.03), area V8 (r = −0.53, p = 0.02) or the PIT complex (r = −0.56, p = 0.015)
and the ventral region as a whole (Table 1). The AUC for prediction of remission was highly significant for PIT
(AUC = 0.90, p < 0.001, 95%CI: 0.72–1). The predictive value for other parcels within the ventral region - e.g.,
FFC (AUC = 0.79, p = 0.008, 95%CI: 0.56–0.96) or V8 (AUC = 0.82, p = 0.005, 95%CI: 0.58–1) - were also significant but below for that of PIT.
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Figure 2. DLPFC and VIS inter-connectivity at baseline. (A) Correlation plot with baseline RSFC data for
DLPFC(p9-46v) – VIS(MT+) associated with improvement in depression (% change in depression scores)
([pre-post/pre] × 100); brain images displayed at Cohen’s d values < 0 (Cohen’s d = 2t/sqrt(dfe)) for DLPFC(p946v) – VIS(MT+), colors represent surface vertices with negative (blue-violet) correlation between RSFC
data and improvement in depression (% change in depression scores) ([pre-post/pre] × 100). (B) Bar plot
with baseline DLPFC(p9-46v) – VIS(MT+) comparison between non-remitters and remitters; bars represent
connectivity values, **p < 0.01. Error bars represent standard error. Brain images display RSFC between
DLPFC(p9-46v) and VIS(MT+) for non-remitters and remitters; colors represent surface vertices with negative
(blue-violet) correlation (−0.3≤ r ≤0.3) with VIS(MT+). (C) ROC curve analysis of DLPFC(p9-46v) –
VIS(MT+) model. AUC, area under the curve; p-val, from Likelihood Ratio Test.
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Figure 3. DMN intra-connectivity at baseline. (A) Correlation plot with baseline RSFC data for within
aDMN(10r), associated with improvement in depression depression (% change in depression scores) ([pre-post/
pre] × 100); brain images displayed at Cohen’s d values < 0 (Cohen’s d = 2t/sqrt(dfe)), colors represent surface
vertices with negative (blue-violet) correlation between RSFC data and improvement in depression depression
(% change in depression scores) ([pre-post/pre] × 100). (B) Bar plot with baseline RSFC within aDMN(10r)
comparison between non-remitters and remitters; bars represent connectivity values; ***p < 0.001. Error bars
represent standard error. (C) ROC curve analysis of RSFC within aDMN(10r) model. AUC, area under the
curve; p-val, from Likelihood Ratio Test.

Two factor models involving specific parcels within MT+ or ventral VIS regions were also assessed with multiple linear and logistic regression. These models were stronger than models involving the overall regions from
which the parcels were taken (Supplementary Results).

Connectivity measures, motion displacement regressors and multiple comparison correction
at baseline. No significant correlation between the mean relative motion displacement from frame-to-frame

and percentage change in depression scores (r = −0.15, p = 0.55), nor between the mean absolute motion displacement from the first fMRI frame and percentage change in depression scores (r = 0.04, p = 0.87), were
observed.
Further inspection of the association between baseline functional connections and change in depression
scores revealed no significant effects of motion displacement (mean absolute or mean relative) on correlation
values (Table 1). After FDR controlled multiple comparison correction, connectivity within aDMN(10r), or
between DLPFC(46) and aDMN(s32), or DLPFC(p9-46v) and VIS(MT+), remained significant (Table 1). Of
note, DLPFC(p9-46v)-VIS(MT+) survived multiple comparison correction after adjusting by motion displacement regressors, in line with the notion of distance-dependence bias58. Within the MT+ region, connectivity
between FST and DLPFC(p9-46v), adjusted by motion displacement regressors, also remained significant after
FDR correction (Table 1).
Finally, LOOCV analyses on FDR corrected models showed 0.83–0.89 accuracy (Table 4).

Changes in connectivity associated with clinical improvement.

In order to identify correlates of
improvement, changes in depression scores were correlated with change in RSFC measures (Supplementary
Table 4). Consistent with predictor models, significant negative correlations were observed between change in
DLPFC(46)-sgACC(25) connectivity and change in symptoms (r = −0.63, p = 0.005), suggesting that increases
in anticorrelation between the parcels correlate with improvements in symptoms.
Similarly, change in connectivity between DLPFC(46) and aDMN(a24) (r = −0.63, p = 0.005), aDMN(s32)
(r = −0.61, p = 0.008; Fig. 6B) or aDMN(10r) (r = −0.60, p = 0.009) all correlated with response, with increases
in anticorrelation between parcels correlating with greater improvement. Similar magnitude correlations were
also observed between treatment response and increase in DLPFC(p9-46v) anticorrelation to these same regions
(aDMN(a24): r = −0.58, p = 0.01; aDMN(s32): r = −0.52, p = 0.03; aDMN(10r): r = −0.55, p = 0.02).
Consistent with predictor models (Fig. 6A), positive correlations were also observed between treatment
response and both increased correlation between DLPFC(p9-46v)-VIS(MT+) (r = 0.56, p = 0.015; Fig. 6B), and
increased anticorrelation between VIS(dorsal)-pDMN(31pv) (r = −0.62, p = 0.007; Fig. 6B).
For within-network correlations, significant positive correlations with treatment response were observed for
intra-DLPFC(46) connectivity (r = 0.65, p = 0.004; Fig. 6B), or connectivity between DLPFC(46) and DLPFC(p946v) (r = 0.69, p = 0.001); for intra-aDMN(10r) connectivity (r = 0.63, p = 0.005; Fig. 6B) or intra-pDMN(31pv/
v23ab) connectivity (r = 0.61, p = 0.007); and for intra-VIS ventral connectivity (i.e., between PIT and the ventral
region as a whole) (r = 0.48, p = 0.04; Fig. 6B).
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Figure 4. VIS intra-connectivity at baseline. (A) (from up-down) Correlation plots with baseline RSFC data
for within VIS(ventral) associated with improvement in depression (% change in depression scores) ([pre-post/
pre] × 100); brain images displayed at Cohen’s d values < 0 (Cohen’s d = 2t/sqrt(dfe)), colors represent surface
vertices with negative (blue-violet) correlation between RSFC data and improvement in depression (% change in
depression scores) ([pre-post/pre] × 100). (B) (from up-down) Bar plot with baseline RSFC within VIS(ventral)
comparison between non-remitters and remitters; bars represent connectivity values; **p < 0.01. Error bars
represent standard error. Brain images display RSFC within VIS(ventral) for non-remitters and remitters, colors
represent surface vertices with negative (blue-violet) or positive (red-yellow) correlation (−0.5≤ r ≤0.5) within
VIS(ventral). (C) ROC curve analyses of RSFC within VIS(ventral) model. AUC, area under the curve; p-val,
from Likelihood Ratio Test.

Parcelwise analysis after ECT. We also examined correlation within individual parcels of MT+ and ventral or dorsal VIS regions (Supplementary Results). Within the MT+ region, strongest (positive) correlations
were observed between LO1 or FST and DLPFC(p9-46v) (Supplementary Table 4). Within the dorsal stream,
strongest (negative) correlations were observed between V3A, V3B, V6A and pDMN(31pv) (Supplementary
Table 4).
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Figure 5. Models for prediction of ECT response. (A) Correlation matrix of pairwise correlation between
pretreatment connections within and between DLPFC, DMN and VIS networks; colors (red, blue) represent
strength of correlations (+1, −1); *<0.05, **<0.01. (B) (from left-right) ROC curve analyses of Model 1:
Baseline RSFC within-VIS(ventral) and within-aDMN(10r). Model 2: Baseline RSFC within-VIS(ventral) and
between DLPFC(46) – DMN(s32). Model 3: Baseline RSFC between DLPFC(p9-46v) – VIS(MT+) and withinVIS(ventral). AUC, area under the curve; p-val, from Likelihood Ratio Test.

Model 1b

Model 2c

Coefficients
Linear regressiona
Step1

Step2

Partiale

Model 3d

Change statistics Coefficients
p-val

R2

p(F)

Partiale

Change statistics Coefficients
p-val

R2

p(F)

DLPFC(p9-46v)-VIS(MT+)
Intra-VIS(ventral)

−0.49

0.048

0.27

0.026

Intra-aDMN(10r)

−0.69

0.003

0.34

0.003

DLPFC(46)-aDMN(s32)

−0.49

0.046

0.27

0.026

0.67

0.003

0.32

0.003

Change statistics

Partiale

p-val

R2

p(F)

−0.62

0.008

0.37

0.007

−0.53

0.03

0.18

0.029

DLPFC(p9-46v)-VIS(MT+)
R2

adj. R2

0.61

0.56

0.60

0.54

0.55

0.49

Table 2. Multiple linear regression Models for prediction of change in depression following ECT, based upon
pre-ECT connectivity patterns. aStepwise method. Step1: 1-factor; Step2: 2-factor. bModel 1: Intra-VIS ventral
and intra-aDMN(10r). cModel 2: Intra-VIS ventral and DLPFC(46)-aDMN(s32). dModel 3: DLPFC(p9-46v)VIS(MT+) and intra-VIS ventral. ePartial correlation coefficients: independent contribution of each factor after
adjusting by the influence of the second factor in Models 1–4.

Logistic regressiona
Remission (HDRS-24 ≤ 7)
Step1

Model 1b

Model 2c

OR per
1 SD

OR per
1 SD

p-val

Model 3d
p-val

DLPFC(p9-46v)-VIS(MT+)

11.56

0.005

0.008

0.17

0.014

Intra-VIS(ventral)

0.14

0.01

0.10

0.005

% Accuracy

Step1

Step2

Step1

Step2

Step1

Step2

Globale

77.8%

100%

77.8%

94.4%

83.3%

94.4%

Non-remitter

77.8%

100%

77.8%

100%

77.8%

100%

Remitter

77.8%

100%

77.8%

88.9%

88.9%

88.9%

DLPFC(46)-DMN(s32)

0.01

p-val

0.09

Intra-DMN(10r)

Step2

0.15

OR per
1 SD

Table 3. Logistic regression of Models for prediction of ECT response. aStepwise method. Step1: 1-factor; Step2:
2-factor. Firth, D. (1993) Bias reduction of maximum likelihood estimates. Biometrika 80, 27–3. bModel 1:
Intra-VIS(ventral) and intra-aDMN(10r). cModel 2: Intra-VIS(ventral) and DLPFC(46)-aDMN(s32). dModel 3:
DLPFC(p9-46v)-VIS(MT+) and intra-VIS(ventral). eAverage accuracy non-remitter and remitter; cut-point 0.5.

Change in connectivity measures, motion displacement regressors and multiple comparison
correction. Finally, no significant effects of motion displacement (mean relative or mean absolute) on the asso-

ciation between change in connectivity and depression scores were observed (Supplementary Table 4). After FDR
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LOOCV analyses
Connectivity at baseline

1-Factor Models

Accuracy

95% CI bootstrapping
(1000 iteration)

Constant

Intra-VIS(ventral)

0.78

0.56

1

Model 1

Intra-aDMN(10r)

0.89

0.61

1

Model 2

DLPFC(46)-aDMN(s32)

0.89

0.61

1

DLPFC(p9-46v)-VIS(MT+)

0.72

0.56

1

DLPFC(p9-46v)-VIS(FST)

0.78

0.56

1

0.83

0.83

1

0.83

0.83

1

0.83

0.83

1

0.89

0.72

1

Model 3

b

Model 1
Model 2
2-Factor Modelsa

Intra-VIS(ventral)
Intra-aDMN(10r)
Intra-VIS(ventral)
DLPFC(46)-aDMN(s32)
DLPFC(p9-46v)-VIS(MT+)

Model 3b

Intra-VIS(ventral)
DLPFC(p9-46v)-MT+ (FST)
Intra-VIS(ventral)

Table 4. Leave-one-out cross validation (LOOCV) analyses on significant FDR corrected Models. Best Models
are highlighted. aAll 2-factor Models include intra-VIS(ventral) connectivity. bModel 3 includes connectivity
between DLPFC(p9-46v) and the entire MT+ region vs. its most significant parcel (FST).

controlled multiple comparison correction, connectivity between DLPFC(46, p9-46v) and aDMN(a24); or between
DLPFC(46) and sgACC(25), aDMN(10r), or aDMN(s32); or between VIS(dorsal) and pDMN(31pv); or within
aDMN(10r), pDMN(31pv/v23ab) or DLPFC(46, p9-46v/46), all remained significant (Supplementary Table 4).

Cortical Thickness and RSFC. No significant effect of treatment response on cortical thickness was found.
Cortical thickness was not associated with remission nor with treatment response.

Discussion

This study evaluated RSFC patterns prior to and following ECT, with the goals of both identifying individuals
who would benefit maximally from ECT treatment and evaluating RSFC changes associated with successful ECT.
As in prior studies of this type23,59–61, pretreatment reduced connectivity (decreased negative correlation) within
the fronto-limbic network, i.e., between DLPFC(46) and area 25, correlated with the magnitude of subsequent
response and significantly predicted which subjects would enter remission. Similar relationships were observed
for connectivity between DLPFC and DMN, also consistent with prior observations59,62–66; our findings regarding
the fronto-limbic and DMN networks are further discussed in Supplementary Discussion.
A novel finding of the present study is that baseline reductions in RSFC between DLPFC and VIS regions, as
well as reduced local connectivity within VIS, also significantly predicted subsequent treatment response, and
changed along with improvement in depression. Moreover, inclusion of pretreatment connectivity reductions
within the ventral VIS region along with other measures in the two-factor prediction algorithm significantly
improved the accuracy of prediction and permitted ~100% discrimination between remitters and non-remitters
within this sample, and >80% accuracy in a confirmatory LOOCV analysis.
VIS disturbances in TRD have previously been demonstrated using task-based activation and functional connectivity45,56,67,68, or metabolite concentration approaches69,70, but RSFC with or within VIS regions and treatment
response in TRD has not been previously investigated. These findings thus provide strong evidence both for VIS
cortical involvement in the pathophysiology of TRD and for the utility of RSFC as a predictor of ECT response
in depression.
In the present study, we used a recently published multimodal parcellation map that permits sub-fractionation
of regional networks into constituent components (“parcels”)2. This allowed us to identify discrete sub-regions
of cortex (e.g., p9-46v, 46, FST, FFC, V8 or PIT; Fig. 7A,B) that may serve as appropriate targets for lower energy,
non-invasive15,71,72 brain stimulation alternative to ECT; e.g., TMS using figure-8 field coils73 is focal (~1.3 cm)
and superficial (0.9–3.4 cm). fMRI-guided TMS may allow identification and targeting of circuit-based targets
using RSFC between specific DLPFC, DMN or VIS parcels, such as connectivity between DLPFC(p9-46v) and
MT+ (FST), or between DLPFC(46) and DMN(s32).
To our knowledge, this is the first study to evaluate RSFC involving VIS cortex as a predictor of treatment
response. Although sensory functions were once considered to be intact in neuropsychiatric disorders, over
recent years there has been increased documentation of VIS cortical dysfunction in conditions such as schizophrenia74, autism spectrum disorder75 and aging76. Higher order VIS2 areas are divided into 3 regions, i.e., dorsal,
ventral and MT+ complex. Consistent with our a priori hypothesis, pretreatment reduced connectivity (reduced
positive correlation) between DLPFCneg and VIS was highly predictive of ECT treatment response including
remission (Fig. 2C). Within DLPFCneg, parcel DLPFC(p9-46v) showed the highest correlation, while within MT+
complex, parcels FST and LO1 were most involved. Accuracy of models based on VIS connectivity were similar
to models involving DLPFC and DMN.
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Figure 6. Baseline vs. change within and between DLPFC, DMN and VIS connectivity. (A,B) (from up-down,
left-right) Schematic representation of RSFC structure at baseline (A) or change after ECT (B) associated with
improvement in depression (% change in depression scores) ([pre-post/pre] × 100); colored straight lines show
significant connections, with positive (+) or negative (−) RSFC correlation with ECT response. Correlation
matrix of pairwise correlation between most significant connections at baseline (A), or change after ECT
(B), within and between DLPFC, DMN and VIS networks and improvement in depression scores (% change
in depression scores) ([pre-post/pre] × 100); colors (red, blue) represent strength of correlations (+1, −1);
*p < 0.05, **p < 0.01. Correlation plots with baseline (A), or change after ECT (B), RSFC data for within and
between DLPFC, DMN and VIS associated with improvement in depression (% change in depression scores)
([pre-post/pre] × 100); colored dot lines show significant connections with positive (+) or negative (−)
correlation from final models.

Furthermore, when RSFC involving ventral VIS regions was included in two-predictor models, significant added predictive value was obtained over and above contributions of DLPFC and DMN (Fig. 5B). Thus,
reduced positive RSFC within ventral VIS (Fig. 4C) and aDMN(10r) (Fig. 3C), or between DLPFC(p9-46v) and
VIS(MT+) (Fig. 2C), or negative RSFC between DLPFC(46) and aDMN(s32) (Fig. 1C), at baseline significantly
predicted ECT response.
Pretreatment DMN-VIS reduced connectivity (reduced negative correlation) also significantly predicted
remission, although to a lesser extent than DLPFC-VIS connectivity; i.e., reduced connectivity between
aDMN(10r) and MT+ VIS (e.g., parcels FST, LO1). After treatment, increased positive RSFC between VIS and
DLPFC, or increase negative between VIS and DMN, were highly correlated to symptom improvement (Fig. 6B).
Finally, reduced positive RSFC within-VIS regions at baseline, especially within the ventral stream (e.g. parcels
FFC, V8, PIT), was highly predictive of remission, with similar classifier performance (AUC) to that for connectivity between DLPFC-aDMN(s32), DLPFC-VIS(MT+) or intra-aDMN(10r). Following ECT, increased positive
correlation within ventral VIS also correlated with magnitude of treatment response (Fig. 6B).
Although the physiological basis for the correlations between VIS connectivity and ECT response are
unknown, regions such as MT+ complex are directly or indirectly coupled to parietal and frontal regions associated with sensory-motor integration77. Multisynaptic inputs in non-human primates from the frontal cortex
to MT+ complex and ventral stream are derived from ventral area 4678, which is possibly involved in carrying
functionally diverse top-down signals to each VIS region (i.e., dorsal, ventral and MT+).
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Figure 7. DLPFCpos versus DLPFCneg and potential targets for TMS. (A) (from left-right) sgACC RSFC map
from an independent cohort of 1200 healthy subjects from HCP was generated to identify more correlated
(DLPFCpos) and anticorrelated (DLPFCneg) left DLPFC coordinates in the same sample of healthy subjects;
colors represent surface vertices with negative (blue-violet) or positive (red-yellow) correlation with the sgACC.
Geodesic map showing the geodesic distance (dg) in mm from average 5-cm MNI coordinates to the rest of the
brain. (B) Potential VIS targets for FMRI-guided TMS.

The MT+ complex incorporates areas in lateral occipital and posterior temporal cortex, and is extensively
activated during both motion and social cognition tasks2. Within MT+, the connectivity in non-human primates
between area FST (dorsal) and the dorsal processing stream directed to posterior parietal cortex is important
in spatial aspects of vision, while FST (ventral) connectivity to the ventral processing stream is related to object
vision79. Thus, the MT+ parcels FST and LO might function as an intermediary of top-down regulation of dorsal
and ventral streams of VIS.
The ventral stream incorporates face-sensitive regions such as FFC2 and PIT80 and color sensitive regions
such as V881. Patients with MDD show increased FFC activity to sad faces and decreased activation to happy
faces82, and slowed face emotion recognition83. Moreover, alterations in color processing are known both scientifically53,84–87 and colloquially (“seeing the world through grey tinted glasses”)88 in depression. More basic deficits
in VIS function, such as alterations in sensory event-related potentials or center-surround inhibition of motion
processing89 are also reported, consistent with our VIS findings.
A surprising result of our study is that the strongest model for prediction of ECT response involved connectivity within ventral VIS by itself, rather than connectivity between VIS and other brain regions, in combination with connectivity within aDMN. Although the basis for the intraregional dysconnectivity is unknown,
both serotonergic and GABAergic theories can be considered. In humans, VIS cortex receives dense serotonergic
innervation. Serotonergic fibers arise in the raphe nuclei and project anteriorly to innervate inferior and medial
prefrontal cortex along with looping posteriorly to terminate in VIS regions. Treatment of depression with the
serotonin 5-HT2A receptor agonist psilocybin improves emotional processing83, suggesting potential serotonergic mediation of the effects. Additionally, ECT-induced changes in several 5-HT-receptor subtypes18,90,91 in the
central nervous system, have also been reported.
Occipital GABA levels are also reduced in MDD92, consistent with center-surround inhibition abnormalities89. Furthermore, such levels increase following ECT93. Both serotonin94 and GABA95–97, may modulate RSFC
in healthy individuals. The present study suggests that disruption of intrinsic connectivity within both VIS and
DMN may indicate both need for and successful response to treatments such as ECT that may function in part
through modulation of serotonergic and GABAergic activity. Thus, to the extent that serotonergic and GABAergic
dysfunction is involved in TRD, disturbances in RSFC between VIS cortex and DLPFC/DMN are expected as part
of a larger RSFC disturbance.
The findings of impaired connectivity within ventral VIS also converge with reported alterations in attention
to happy vs. sad faces in depression. Connectivity within VIS cortex, including ventral VIS, may be modulated
by top-down connections from DLPFC and limbic regions such as amygdala or sgACC98–101. Thus, even though
connectivity was obtained during the resting state, it is possible that decreased top-down DLPFC or increased
top-down limbic modulation of VIS may have contributed to the present results. Future studies evaluating modulation of RSFC as a function of attention to affective stimuli are therefore required.
Alternatively, intrinsic abnormalities of ventral VIS connectivity may lead to intrinsic biases in VIS function
that cannot be overcome through usual top-down control mechanisms. VIS connectivity may also be indexed
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by generation of the posterior alpha rhythm, with reduced connectivity associated to an alpha synchronization
deficit102. Alpha rhythms in parieto-occipital cortex are controlled by top-down signals103 and their disruption
might lead to a suboptimal state of neural synchronization. Future studies would thus be needed to evaluate the
potential utility of resting posterior alpha for prediction of ECT response.
Based upon the present pattern of results, we propose a dysfunction in the hierarchical organization within
and between VIS, DMN, and DLPFCneg subnetworks as a new biomarker of ECT response, which also sheds light
on underlying mechanisms. Specifically, we observed that TRD patients who show the best response to ECT show
a pretreatment pattern characterized by reduced anti-correlation between DLPFCneg-DMN and DMN-VIS, as
well as reduced positive correlation between VIS-DLPFCneg or within VIS and DMN (Fig. 6A).
Moreover, effective ECT increases the strength of anti-correlations between DMN and DLPFC or VIS, and of
the positive correlation between VIS and DLPFCneg (Fig. 6B), or within VIS and DMN. The resting anticorrelation
between DLPFC and DMN is extensively studied and serves as the basis for suppression of DMN during active
task conditions. Our results suggest that failures of deactivation may result in part from reduced connectivity
both within DMN and between DMN and DLPFC. The VIS-DLPFC correlation is also studied in the context of
attentional filtering of distracting information (bottom-up/top-down inhibitory control of the distractor related
processing). The VIS-DMN anti-correlation is less studied, but may underlie the ability of VIS stimuli also to
suppress DMN activity104.
Aberrant DMN connectivity is well established in MDD29,105,106, including TRD32,107. The present findings suggest that ECT may function primarily to restore the normal108 anti-correlation of DMN with both “top down” and
“bottom up” networks, in order to suppress ongoing DMN hyperactivity that may be associated with increased
“mind wandering” relative to goal-directed activity. Positive connectivity between DLPFC and VIS regions is
critical for normal goal-directed VIS activity109. ECT-induced changes in connectivity may therefore restore both
baseline VIS biases and top-down VIS control. Interestingly, our study implicates both face- (e.g. FFC, PIT) and
color- (e.g. V8) parcels within ventral VIS, consistent with popular depictions of the disorder.
The only model to obtain 100% accuracy in both logistic regression and ROC analyses involved connectivity
within ventral VIS and aDMN(10r) (Model 1, Table 3), or aDMN(s32/10r) (Model 5, Supplementary Table 3). The
rostral MPFC (i.e., 10r) is considered a focal point of neural communication, participating in multiple functional
networks and enabling high levels of functional diversity (functional hub)110. Disturbances of this hub region and
their interconnections are likely to cause severe impairments due to their influential role in global integrative
processes.
Our results showed abnormal functioning of this hub region was associated to disturbances in the pattern
of dynamic interactions (outgoing projections) with central regions of attentional networks, such as DLPFC
and VIS, with decreased connectivity intra-aDMN(10r) associated to decreased connectivity intra-DLPFC or
DLPFC-VIS, and DLPFC-DMN or DMN-VIS (connected components) (Fig. 5A), reinforcing the central role
for 10r hub node in the overall network structure and dynamical organization. Depression has also been associated with abnormal topological organization of brain networks, including disrupted global integrity and regional
connectivity111.
On the other hand, decreased intra-VIS connectivity was only associated to decreased intra-DLPFC connectivity (Fig. 5A), consistent with the observation of primary regions (e.g., VIS) to participate in small number of
functional networks compared to the participation of 10r in multiple functional networks110. Consistent with
current results, Zhang et al.112 showed decreased regional connectivity (degree efficiency and betweenness) in the
DLPFC and occipital regions. As such, the model combining both, RSFC within 10r and ventral VIS, includes two
core non-overlapping components of the overall network dysfunction in TRD.
The posterior alpha network comprises the occipital lobe and parts of the temporal and medial
posterior-parietal cortex (including posterior cingulate gyrus and precuneus) and temporal lobes113. After effective treatment, connectivity changes within (increased correlation) and between VIS and pDMN (increased
anticorrelation) were associated with good response. Connectivity changes propagated through the entire VIS
network including MT+ complex (e.g., FST, L03, V3CD), dorsal stream (e.g., V3A, V3B, V6A, V7) and ventral
stream (e.g., PIT), extending to pDMN (e.g., 31pv, v23ab), suggesting modulatory effects in the intrinsic activity
of VIS system.
In addition to predicting ECT response, the present results argue for a move in scalp location of the standard
TMS probe placement ≥ 20–50 mm of geodesic distance (dg) (defined as the length of the shortest directed path
from the current canonical location) from the present location which is defined based upon the 5cm-rule (corresponding to vertex 30641) (Fig. 7A). Furthermore, it argues strongly for individual targeting of rTMS to areas
46 or p9-46v, which correspond to the parcels of DLPFC region that are anti-correlated to sgACC (DLPFCneg).
These findings are consistent with those of Fox et al.15,71,72, who also suggested that the DLPFCneg (BA46) region
may serve as a critical treatment target in depression, and support the role of DLPFC-sgACC, DLPFC-aDMN,
and DLPFC-VIS RSFC both as predictors of need for ECT, and correlates of change.
There are several limitations of the present study. First, the sample size is relatively small, necessitating replication in larger cohorts. There were also no cohorts receiving other treatment types (e.g. antidepressants, ketamine)
so that it is unknown whether the network effects predict general treatment response or response specifically to
ECT.
Second, in order to obtain 100% correct classification, we required use of two independent predictors. Because
the model was not pre-specified, the present results must be considered exploratory and must be confirmed in a
future sample. Nevertheless, analyses were constrained using a pre-planned parcellation scheme, which limited
the number of comparisons. Specifically, DLPFCneg, sgACC, aDMN, ventral VIS and MT+ complex were all identified a priori. DLPFCneg-sgACC and DLPFCneg were selected for analyses based upon prior literature. Although
3 VIS regions were used in analyses, the findings regarding DLPFC-MT+ connectivity were sufficiently strong
to survive FDR correction for multiple comparisons. The findings with intra-ventral connectivity were weaker,
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but were additive to several other connectivities (DLPFC-sgACC, DLPFC-aDMN, DLPFC-VIS, intra-aDMN),
providing convergent support. Predictive models showed 0.83–0.89 accuracy in LOOCV analyses even following
control by motion regressors and FDR correction, and thus support further studies with this algorithm.
As opposed to the present study, a recent study114 evaluated changes in patients with schizophrenia treated
with combined antipsychotics and ECT, and showed a five-predictor algorithm (i.e., DMN, temporal lobe network, language network, cortico-striatal network and fronto-parietal network) that correctly classified 83.8%
of 13 patients, suggesting that multiple predictors do not, of necessity, produce high predictive values. Here, by
uniquely incorporating VIS RSFC measures in our algorithm, we obtain 100% correct classification in a sample
of comparable size and with only one- or two-predictors.
Finally, since there is not a multi-modal subcortical parcellation available at this time, we considered only
cortical structures in the present study. By contrast, a recent study demonstrated that DLPFC-striatal connectivity significantly predicted TMS response115. Thus, future studies incorporating both cortical and subcortical
structures are needed.

Methods

Participants. We studied 18 TRD patients receiving ECT for clinical indications at New York State Psychiatry
Institute (NYSPI) or Columbia University Medical Center (CUMC) (ages: 18–75; mean = 52, SD = 12), who
met DSM-IV criteria for a Major Depressive Episode (MDE) according to the diagnostic assessment by the
Structured Clinical Interview Patient Edition (SCID-P), with scores of 18 or greater (mean = 26.5, SD = 3.9) on
the 24-Hamilton Depression Scale (HDRS-24). Patients with comorbid other Axis I or Axis II psychiatric disorders were excluded. All subjects were right-handed and without severe medical conditions. The NYSPI/CUMC
Institutional Review Board approved this study. All participants provided written informed consent. This study
was performed in accordance with all relevant guidelines and regulations.
Electroconvulsive therapy.

Participants received a full course of right unilateral, frontal ECT. ECT and
anesthesia procedures complied with APA Guidelines116. Blood pressure, pulse, ECG, and pulse oximetry were
monitored prior to anesthetic induction and continuously during the procedure. Seizure manifestations were
recorded with two frontal-mastoid EEG channels, as well as motor manifestations with the cuff technique. Using
conservative criteria (≥15 seconds), generalized seizures of adequate duration were elicited at each treatment.
Ultra-brief right unilateral (RUL) ECT was given with a Thymatron System IV brief pulse device. Seizure threshold (ST) was determined at the first treatment using the dose titration method117. Dose at subsequent treatments
was at 6xST or maxim output, whichever was lower. Patients remained on pre-existing antidepressant medication
without alteration over the course of the study.
The Hamilton118 rating scale (HDRS, 24 items) was obtained pre/post ECT and used for outcome analyses.

fMRI Data Acquisition and Processing.

High resolution anatomical images and resting-state functional
MRI were collected pre/post ECT. Post study imaging was performed approximately 48–72 hours after the last
treatment to allow sufficient time for recovery from treatment. Anatomical and functional imaging data from
each subject were collected and processed using acquisition guidelines and processing pipelines provided by
the Human Connectome Project (HCP)119. Collected data was also compared to the healthy individuals from
the HCP database (https://www.humanconnectome.org/study/hcp-young-adult/data-releases). High-resolution
functional imaging scans were completed at the MRI facility at NYSPI using a GE Discovery MR750 3.0 Tesla full
body MR system equipped with a 32-channel phased array head coil (Nova Medical, Wilmington MA).
Subjects were placed in the scanner with head cushioning to restrict head movement. Following localizer scans
(5 minutes), distortion correction scans (B0 fieldmap), a pair of T1-weighted images, and a T2-weighted image
are acquired over 25 minutes, followed by one 10-minute resting state fMRI scan. Total scan time was 45 min.
Sessions were conducted prior to and following completion of the course of ECT. T1-weighted images acquired
for anatomical co-registration were transverse T1-weighted BRAVO sequence with the following acquisition
parameters: 3D sagittal, 0.8 mm isotropic, matrix size = 300 × 300, slices = 220, TR = 7.856 ms, TE = 3.108 ms,
flip angle = 12°, TI = 450 ms and CUBE T2-weighted image was acquired with these parameters; 3D sagittal,
0.8 mm isotropic, matrix = 320 × 320, # of slices = 220, TR = 2500 ms, TE = 95.708 ms, flip angle = 90°.
Functional images were acquired with a GE-EPI sequence (2.5 mm isotopic, slice plane = transverse,
TR = 2500 ms, SENSE factor = 2, TE = 22 ms, matrix = 96 × 96, slices = 54, phase encode = A −> P); an instruction was given to all patients before the functional MRI sequence to have their eyes opened. Images were transferred to a workstation with the HCP processing pipeline version 3.4 installed. The pipeline implements standard
automated structural and fMRI processing (movement correction, atlas realignment, creation of cortical surface
model etc.) with FSL 5.0.6, FreeSurfer v5.3.0-HCP, and Connectome Workbench v1.0, and two additional procedures that improve upon standard preprocessing: required use of field-mapping sequences to “undistort” GE-EPI
images and creation of a “gray-ordinate” CIFTI-format files that only contained data from cortical and subcortical
gray matter. The HCP pipelines were modified to a) process the B0 fieldmaps produced by the GE MR scanner
and b) to implement slice-time correction (fMRIVolume processing pipeline set to ODD for interleaved).
Resulting structural and functional data were aligned in volume space to the MNI152 atlas and in surface
space to the HCP-generated Conte69 surface atlas based on cortical folding patterns. Resting-state data files have
undergone removal by regression of CSF, white matter, whole brain, and movement parameters (6 translation/
rotation parameters + quadratic combinations of the 6 parameters + derivatives of these 12 parameters); to avoid
slice-time correction affecting the movement parameters, movement parameters were derived from the data
before HCP processing120. Frames with FD >0.2 mm and/or DVARS with >(75percentile) + (1.5) × (interquartile range) (fsl defaults) were then censored and interpolated121,122, and then a bandpass filter with a low cutoff of
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0.0005 Hz and high cutoff of 0.2 Hz was applied. Subsequent analyses only used the non-censored frames (they
did not include the interpolated frames).
Even though the most common approach for removing global structured noise is to remove the mean (across
space) fMRI timecourse from the data using global signal regression123, there are some limitations associated to
this approach given that global signal may differ between patients with psychiatric disorders124,125, and because
the removal of neural signal may distort the resulting connectivity measures in network-specific ways126.

Definition of ROIs.

Regions of interest (ROI) for these analyses were defined using the multi-modal parcellation2 of human cortex (Supplementary Table 5); all ROIs used for analyses were bilateral. DLPFC, DMN and VIS
networks were created manually following grouped regions from the multi-modal parcellation (Supplementary
Fig. 1A–C).
The sgACC ROI (area 25) was first used as a seed on an independent cohort of 1200 healthy subjects from
the HCP database. The sgACC RSFC map generated across 1200 healthy subjects from the HCP dataset was
used to find parcels within the DLPFC region2 with highest negative (DLPFCneg) correlation with the sgACC
(Supplementary Fig. 2), based on previous findings15. These negative areas (46, p9-46v, a9-46v, 9-46d) within the
DLPFC were used to create our DLPFCneg masks.
Regions within the anterior (aDMN: a24, s32, 10r) or posterior (pDMN: 31pv, v23ab) medial locus of DMN
were selected based on their strongest association in the resting-state with task negative, as shown in Glasser et
al.2. Main parcels within rostral ACC (a24, s32) were also selected based on early studies on predictors of treatment response64,127. MNI coordinates from the core set of hubs, rostral MPFC (−6 52 −2) or PCC (−8 −56 26)
based on previous work36, were approximately128 mapped to Glasser parcels rostral MPFC (10r; surface vertex
28169) or PCC (31pv, v23ab; surface vertex 26238), respectively. These cortical areas were used to create our
aDMN or pDMN masks.
The VIS network has been divided into primary VIS (V1), early VIS (V2-V3), dorsal stream, ventral stream and
MT+ complex regions. We exclusively focused on higher order VIS regions, grouped into three separate subsystems: dorsal and ventral streams and MT+ complex. These separate subsystems were used to create our VIS masks.

Seed-based RSFC analyses. Baseline RSFC maps of areas within the DLPFCneg (46, p9-46v, a9-46v, 9-46d)

were first created for each TRD patient to explore patterns of connectivity with sgACC (25) and rostral ACC (a24)
as predictors of treatment response. Cortical areas within the DLPFCneg with predictive power (46, p9-46v) were
then selected to further explore patterns of connectivity with DMN and VIS networks.
RSFC maps of areas within the aDMN (s32, 10r) and pDMN (31pv, v23ab) were created for each TRD patient
to further explore patterns of connectivity with VIS network.
RSFC maps of each separate region of VIS network (dorsal, ventral and MT+) were created for each TRD
patient to explore patterns of intra-VIS connectivity (intra-regional connectivity). First, the spatial map of each
VIS region was used as the predefined mask. Then, RSFC of each VIS region to all voxels in each predefined
mask was computed and averaged as the intra-regional connectivity (intra-ventral, intra-dorsal and intra-MT+).
Following detection of significant within regional correlations, secondary analyses evaluated the relative contribution of individual parcels within each region by computing parcel-to-region connectivity within region (e.g.,
FFC to ventral).

Network analyses. Initial RSFC analyses explored patterns of connectivity between 4 cortical areas within
the DLPFCneg (46, p9-46v, a9-46v, 9-46d) and 2 cortical areas within the sgACC (25) or the rostral ACC (a24); 8
correlation analyses were conducted. Subsequent RSFC analyses were based on a network configuration of 9 ROIs: 2
cortical areas within the DLPFCneg (46, p9-46v), 2 cortical regions within aDMN (s32, 10r), 2 cortical regions within
pDMN (31pv, v23ab), and 3 VIS subsystems focused on higher order VIS regions (dorsal, ventral and MT+). Using
the RSFC measures obtained from this network, we analyzed (1) within-network RSFC, averaged across hemispheres, and (2) between-network RSFC, averaged across hemispheres; 38 correlation analyses were conducted.
Analyses focused first on prediction of the degree of treatment response and remission across individuals; and subsequently on correlates of change. Follow-up VIS analyses focused on significant patterns of connectivity between
DLPFC(p9-46v) or DMN(31pv) and VIS(MT+, dorsal), or within VIS(ventral), to evaluate the relative contribution
of individual parcels within each VIS region (7 parcels for ventral, 6 parcels for dorsal, 9 parcels for MT+).
Fisher’s z transform was applied to individual RSFC maps before group level analyses; uncorrected p-values
were reported as only 8 (for initial analyses) and 38 (for network-analyses) comparisons were made; corrected
p-values using FDR129 controlled multiple comparison correction were computed to see whether any of the
uncorrected p-values survived. Leave-one-out cross validation (LOOCV) analysis was conducted on FDR corrected predictive models to estimate potential predictive value when applied to larger samples.
Influence of motion regressors on depression scores and connectivity. We evaluated if depression scores or connectivity measures were linked to motion estimators. The HCP pipeline provides an estimate
of average displacement from initial frame (mean absolute) and frame-to-frame (mean relative) displacement
for each run and fMRI session. We evaluated linear trends between percentage change in depression scores and
subject’s motion displacement values (Corr), or between percentage change in depression scores and baseline/
change in connectivity measures controlling by subject’s motion displacement values (PCorr). Corrected p-values
using FDR129 were also computed to see whether any of the uncorrected p-values, adjusted by subject’s motion
displacement values, survived.
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Statistics. All analyses were conducted using R-package (version 3.5.1). To investigate association between
continuous variables, Pearson’s correlation and partial correlation analyses were used. Partial correlation analyses
were adjusted by motion displacement values (mean absolute and mean relative).
Initial analyses were performed using simple correlations between each pretreatment RSFC measure and
percent change in depressive symptoms, defined as percentage change in HDRS-24 ([pre-post]/pre] × 100%).
Multiple linear regression analyses were then conducted to evaluate the potential additive value of significant
functional connections to identify best two-factor predictive models of percentage change in HDRS-24. The
ability of pretreatment RSFC patterns to predict symptom remission, defined as final HDRS-24 score ≤ 7, was
assessed using multiple logistic regression and the area under the receiver operating characteristic (ROC) curve.
ROC analyses were conducted using R-package pROC (version 1.8)130,131; confidence interval (95% CI) used
bootstrapping (2000 stratified bootstrap replicates). Leave-one-out cross validation (LOOCV) analysis was conducted on FDR corrected predictive models; confidence interval (95% CI) of accuracy measure used bootstrapping (1000 iteration). Subsequent analyses used simple correlation analyses to asses ECT-induced changes on
baseline connectivity measures by computing correlation between (post-pre) connectivity measures and percent
change in depressive symptoms. For two group comparisons, two-sample t-test were used. Sample descriptive
statistics for continuous variables are reported as mean ± s.e. All statistics are two-tailed, with preset alpha level
for significance of p < 0.05, and n value of 18.
Cortical Thickness and RSFC. To confirm that changes in cortical thickness did not affect RSFC analyses,
cortical thickness was evaluated (Supplementary Methods) as a function of both time (pre/post ECT) and group
(remitter/non-remitter), using repeated ANOVA. In addition, we computed correlation analyses between changes
in cortical thickness and improvement in depression. Across analyses, no significant relationships were observed
between cortical thickness and ECT response.
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